The 25 dead and hundreds sickened by tainted drugs made at a Framingham company do not represent the first occasion in which the largely unregulated compounding industry has caused harm, according to a report from US Representative Edward J. Markey.
Not including the recent fungal meningitis outbreak, problematic practices at compounding pharmacies have been associated with at least 23 deaths and 86 cases of serious illness, according to the congressman’s report, which cites Food and Drug Administration records and media reports.
Comments
The report from Rep. Markey on pharmacy compounding can be found at the Web site for his Congressional office. [ Rep. Edward J. Markey (D, MA), Compounding pharmacies compounding risk, October 29, 2012, at http://markey.house.gov/sites/markey.house.gov/files/documents/Compounding%20Pharmacies%20-%20Compounding%20Risk%20FINAL_0.pdf ] ----------------------------------------------------------------------------------------------------------- The report calls attention to a so-called "safe drug compounding act of 2007" that was never even filed as a bill in Congress. Drafted by staff of the late Sen. Kennedy, it was circulated by e-mail early in 2007 and quickly attacked by industry lobbyists. Apparently there is no remaining copy available on the Web. [ Thomas M. Burton, James V. Grimaldi and Timothy W. Martin, Pharmacies fought controls, Wall Street Journal, October 14, 2012, at http://online.wsj.com/article/SB10000872396390444657804578052972230404046.html ]
Here comes Markey again. Days late and dollars short. He's always barking AFTER the fact, making it appear he's doing something, when all he's doing is talking.
This comment has been removed.
Deval Patrick & his well paid regulators were asleep at the switch failing to perform their responsibilities.
Some of this may have been caught if they were performing their duties.
This comment has been removed.
This comment has been removed.